Business news – Page 93
-
Business
Nice rules against Afinitor
Novartis’ drug will not routinely be available on the UK health service
-
Business
Syngenta takes legal action over pesticide ban
Company claims that the European commission’s two-year moratorium on neonicotinoids to protect bees was wrong
-
Business
Couple charged in GSK corruption investigation
Two private investigators have been charged with breaching the privacy rights of Chinese citizens
-
Business
J&J buys Aragon’s prostate cancer arm
Hormone cancer specialist spins out other programmes before sale
-
BusinessTwo way traffic for Chinese drug licensing
Western companies are seeing more value in Chinese innovation
-
Business
Boehringer to close manufacturing plants and cut jobs
Two US plants and a total of 640 jobs to go by the end of next year
-
BusinessAkzoNobel sells building adhesives unit for €260m
Sika will take on two manufacturing sites and 550 employees
-
BusinessObama mandate calls for safer chemical facilities
Agencies need to work together more effectively to improve safety
-
Business
Antiviral patents released by Roche
Firm will supply cheap drugs and allow generics in developing countries
-
Business
India revokes more pharma patents
Original molecule patent stands, but a new salt form is ‘not innovative’
-
BusinessPfizer reshuffle hints at future split decision
Could pharma giant’s ‘value’ and ‘innovative’ segments get broken apart?
-
Business
Perrigo bags Elan and its bargain Irish tax rates
$8.6bn deal ends Elan’s takeover battle with Royalty Pharma
-
Business
Thousands face job cuts after Valeant's Bausch buyout
Valeant plans to shed 10-15% of its workforce to save $800 million
-
BusinessChina corruption investigation broadens
GSK scandal is the trigger to clean up Chinese drug market
-
BusinessGas specialist branches out into carbon nanotubes
Linde group launches ink made with long, individual tubes
-
FeaturePhasing out fire retardants
With many brominated flame retardants facing bans, Nuala Moran examines the industry’s dash for new ones
-
BusinessLilly freezes pay as patent cliff looms
Drugmaker targets $400 million savings as two key patents near expiry
-
Business
PolyOne to close six sites and shed 250 jobs
Former Spartech manufacturing facilities are ‘redundant’ after takeover in March